Syncom Formulation (India) (NSE:SYNCOMF) EBIT per Share : ₹0.62 (TTM As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Syncom Formulation (India) EBIT per Share?

Syncom Formulation (India)'s EBIT per Share for the three months ended in Sep. 2024 was ₹0.22. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 was ₹0.62.

During the past 12 months, the average EBIT per Share Growth Rate of Syncom Formulation (India) was 86.40% per year. During the past 3 years, the average EBIT per Share Growth Rate was -14.80% per year. During the past 5 years, the average EBIT per Share Growth Rate was 14.20% per year. During the past 10 years, the average EBIT per Share Growth Rate was 2.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Syncom Formulation (India)'s EBIT per Share or its related term are showing as below:

NSE:SYNCOMF' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -72.6 Med: -10.5 Max: 239.6
Current: -14.8

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Syncom Formulation (India) was 239.60% per year. The lowest was -72.60% per year. And the median was -10.50% per year.

NSE:SYNCOMF's 3-Year EBIT Growth Rate is ranked worse than
80.65% of 837 companies
in the Drug Manufacturers industry
Industry Median: 6.8 vs NSE:SYNCOMF: -14.80

Syncom Formulation (India)'s EBIT for the three months ended in Sep. 2024 was ₹150 Mil.

Syncom Formulation (India) EBIT per Share Historical Data

The historical data trend for Syncom Formulation (India)'s EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syncom Formulation (India) EBIT per Share Chart

Syncom Formulation (India) Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EBIT per Share

Get a 7-Day Free Trial

0.21

0.51

0.32

0.41

Syncom Formulation (India) Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EBIT per Share	Get a 7-Day Free Trial															0.12	0.13	0.12	0.15	0.22

Syncom Formulation (India) EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Syncom Formulation (India)'s EBIT per Share for the fiscal year that ended in Mar. 2024 is calculated as

	EBIT per Share		(A: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	383.088	/	940.000
=	0.41

Syncom Formulation (India)'s EBIT per Share for the quarter that ended in Sep. 2024 is calculated as

	EBIT per Share		(Q: Sep. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	150.103	/	694.263
=	0.22

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.62

Syncom Formulation (India) (NSE:SYNCOMF) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Syncom Formulation (India) EBIT per Share Related Terms

Thank you for viewing the detailed overview of Syncom Formulation (India)'s EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Syncom Formulation (India) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Syncom Formulation (India) Ltd (NSE:SYNCOMF) » Definitions » EBIT per Share

Traded in Other Exchanges

524470:India

Address

207, Saket Nagar, Near Saket Club, Indore, MP, IND, 452018

Website

https://www.sfil.in

Syncom Formulation (India) Ltd is in the business of pharmaceuticals. The company operates through three segments including manufacturing and dealings in Pharmaceutical drugs and formulations, Trading of commodities, and Renting of property. It manufactures and markets pharmaceutical formulation products in various dosage forms like tablets, capsules, liquids orals, liquids vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and Herbals. The company's product includes generic, antiviral, antidepressant, cough suppressant, electrolyte, histamine, estrogen, and much more. It generates maximum revenue through the Pharmaceutical drugs and formulations segment.

Syncom Formulation (India) Headlines

No Headlines